Association of M2BPGi with Subclinical Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease

More on Metabolic dysfunction-associated steatotic liver disease

• Cardiometabolic burden is linked to CVD and death in MASLD

  Frontiers in Nutrition · 4 Oct 2026

  

• A 5:2 fasting regimen curbs muscle impairment in mice

  Journal of Cachexia, Sarcopenia and Muscle · 5 Oct 2026

  

• NMR metabolomics improves prediction of cardiometabolic diseases

  medRxiv · 4 Oct 2026

  

• Nutrient deficits linked to higher metabolic risks in obesity

  Nutrients · 4 Oct 2026